CDK4 and urinary bladder carcinoma: In addition, analysis of TCGA expression data via gene expression profiling interactive analysis (GEPIA) demonstrated that CDK1, cyclinA2 and cyclinB1 are observed at increased expression levels in bladder cancer tissues, whereas CDK2, CDK4 and cyclinD1 are not differentially expressed (Fig. S5G).